

Brian Kennedy on Rapamycin Master Series | Aging is the biggest risk factor for age-related diseases
Oct 17, 2023
Leading researcher Brian Kennedy discusses his extensive longevity research experience, his involvement in longevity companies, and his current longevity research project in Singapore. Topics include early discoveries in longevity research, the significance of the TORE pathway in nutrient signaling and longevity, the efficacy of NAD precursors, plans for the Rapa Mysen trial, exploring rapamycin derivatives, and the debate surrounding high protein vs low protein intake.
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7
Introduction
00:00 • 2min
Early Days and Discoveries in Longevity Research
01:52 • 5min
Exploring the TORE pathway and its role in nutrient signaling and longevity
07:02 • 27min
Exploring NAD Precursors and their Efficacy
34:07 • 15min
Plans for the Rapa Mysen trial and considerations for the study population
49:11 • 2min
Exploring Rapamycin Derivatives and Other Ways to Inhibit mtorc
51:40 • 3min
High Protein vs Low Protein
54:23 • 16min